印加果油辅酶Q10植物软胶囊

描述

印加果油的好处：
Omega-3和9
-降低三高（高血压 [1]、高血脂 [2]、高血糖 [3]）
-改善心血管（心脏和血管疾病 [4]），降低中风和老年痴呆的风险
-促进新陈代谢，帮助减肥和增肌（刺激胰岛素的敏感度）
-改善睡眠
-保持皮肤弹性，锁住肌肤表面水分及光滑皮肤

Omega-6
-帮助减少油脂和改善胰岛素敏感度 [5]
-加强身体的免疫力
-调节荷尔蒙水平
-促进细胞更新（例如修复晒伤的皮肤）
-维持骨骼健康

Vitamin K1
-有助于伤口愈合和防止大量出血
-可帮助心血管健康 [6]
-可降低换上糖尿病的风险 [7]

维生素E：
-有效的脂溶性抗氧化剂，避免体内有过高的氧化反应
-可帮助减低患上心脏病的机率 [8][9]

辅酶Q10
-增强心脏机能
-改善并强化心血管系统-避免心脏衰竭 [10][11][12]
-帮助维持正常血压-减少中风机率[13]
-提高人体免疫力、增强抗氧化、延缓衰老和增强人体活力等功能。
-可帮助减少偏头痛的问题 [14]

适合对象：
高胆固醇、高血压、高血糖、有心脏疾病、肥胖人士及素食者

成分
印加果油
维生素E
辅酶Q10

食用方式
每天1-2粒，餐后服用

包装
60颗植物软胶囊 x 500MG

所获标准认证：
-国际GMP 标准药厂认证
-ISO 9001质量管理体系认证
-HALAL 认证
-VEGAN
-产品责任保险高达1百万

参考资料：
[1] A. E. Naini, N. Keyvandarian, M. Mortazavi, S. Taheri, and S. M. Hosseini, “Effect of Omega-3 fatty acids on blood pressure and serum lipids in continuous ambulatory peritoneal dialysis patients,” J. Res. Pharm. Pract., vol. 4, no. 3, p. 135, 2015, doi: 10.4103/2279-042X.162356.
[2] A. AN, O. Á. JG, and E. J. I, “Metabolic status is related to the effects of adding of sacha inchi (Plukenetia volubilis L.) oil on postprandial inflammation and lipid profile: Randomized, crossover clinical trial,” J. Food Biochem., vol. 43, no. 2, Feb. 2019, doi: 10.1111/JFBC.12703.
[3] A. N. Alayón, J. G. Ortega Avila, I. Echeverri Jimenez, and I. Echeverri Jiménez, “Carbohydrate metabolism and gene expression of sirtuin in healthy subjects after Sacha Inchi supplementation: A randomized trial,” no. 3, Mar. 2013, doi: 10.1039/C7FO01956D.
[4] S. U. Khan et al., “Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis,” EClinicalMedicine, vol. 000, p. 100997, 2021, doi: 10.1016/j.eclinm.2021.100997.
[5] K. C. Maki, F. Eren, M. E. Cassens, M. R. Dicklin, and M. H. Davidson, “ω-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps,” Adv. Nutr., vol. 9, no. 6, pp. 688–700, 2018, doi: 10.1093/advances/nmy038.
[6] S. MK et al., “Vitamin K supplementation and progression of coronary artery calcium in older men and women,” Am. J. Clin. Nutr., vol. 89, no. 6, pp. 1799–1807, Jan. 2009, doi: 10.3945/AJCN.2008.27338.
[7] J. W. J. Beulens, D. L. van der A, D. E. Grobbee, I. Sluijs, A. M. W. Spijkerman, and Y. T. van der Schouw, “Dietary Phylloquinone and Menaquinones Intakes and Risk of Type 2 Diabetes,” Diabetes Care, vol. 33, no. 8, pp. 1699–1705, Aug. 2010, doi: 10.2337/DC09-2302.
[8] E. B. Rimm, M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, and W. C. Willett, “Vitamin E Consumption and the Risk of Coronary Heart Disease in Men,” http://dx.doi.org/10.1056/NEJM199305203282004, vol. 328, no. 20, pp. 1450–1456, Jan. 2010, doi: 10.1056/NEJM199305203282004.
[9] M. J. Stampfer, C. H. Hennekens, J. E. Manson, G. A. Colditz, B. Rosner, and W. C. Willett, “Vitamin E Consumption and the Risk of Coronary Disease in Women,” http://dx.doi.org/10.1056/NEJM199305203282003, vol. 328, no. 20, pp. 1444–1449, Jan. 2010, doi: 10.1056/NEJM199305203282003.
[10] I. P. de Barcelos and R. H. Haas, “CoQ10 and Aging,” Biology (Basel)., vol. 8, no. 2, Jun. 2019, doi: 10.3390/BIOLOGY8020028.
[11] J. J. DiNicolantonio, J. Bhutani, M. F. McCarty, and J. H. O’Keefe, “Coenzyme Q10 for the treatment of heart failure: a review of the literature,” Open Hear., vol. 2, no. 1, p. e000326, Oct. 2015, doi: 10.1136/OPENHRT-2015-000326.
[12] A. Martelli, L. Testai, A. Colletti, and A. F. G. Cicero, “Coenzyme Q10: Clinical Applications in Cardiovascular Diseases,” Antioxidants, vol. 9, no. 4, Apr. 2020, doi: 10.3390/ANTIOX9040341.
[13] S. L et al., “Serum Coenzyme Q10 Is Associated with Clinical Neurological Outcomes in Acute Stroke Patients,” J. Mol. Neurosci., vol. 66, no. 1, pp. 53–58, Sep. 2018, doi: 10.1007/S12031-018-1115-1.
[14] S. PS et al., “Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial,” Neurology, vol. 64, no. 4, pp. 713–715, Feb. 2005, doi: 10.1212/01.WNL.0000151975.03598.ED.